279 related articles for article (PubMed ID: 10868465)
21. Tardive dyskinesias and antipsychotics: a review.
Llorca PM; Chereau I; Bayle FJ; Lancon C
Eur Psychiatry; 2002 May; 17(3):129-38. PubMed ID: 12052573
[TBL] [Abstract][Full Text] [Related]
22. Bodyweight gain with atypical antipsychotics. A comparative review.
Wetterling T
Drug Saf; 2001 Jan; 24(1):59-73. PubMed ID: 11219487
[TBL] [Abstract][Full Text] [Related]
23. The pharmacology of weight gain with antipsychotics.
Casey DE; Zorn SH
J Clin Psychiatry; 2001; 62 Suppl 7():4-10. PubMed ID: 11346195
[TBL] [Abstract][Full Text] [Related]
24. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review.
Newcomer JW
CNS Drugs; 2005; 19 Suppl 1():1-93. PubMed ID: 15998156
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
Lieberman JA; Stroup TS; McEvoy JP; Swartz MS; Rosenheck RA; Perkins DO; Keefe RS; Davis SM; Davis CE; Lebowitz BD; Severe J; Hsiao JK;
N Engl J Med; 2005 Sep; 353(12):1209-23. PubMed ID: 16172203
[TBL] [Abstract][Full Text] [Related]
26. Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases.
Croarkin PE; Emslie GJ; Mayes TL
J Clin Psychiatry; 2008 Jul; 69(7):1157-65. PubMed ID: 18572981
[TBL] [Abstract][Full Text] [Related]
27. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
[TBL] [Abstract][Full Text] [Related]
28. Akathisia and second-generation antipsychotic drugs.
Kumar R; Sachdev PS
Curr Opin Psychiatry; 2009 May; 22(3):293-99. PubMed ID: 19378382
[TBL] [Abstract][Full Text] [Related]
29. [New i.e. atypical neuroleptic agents for negative symptoms of schizophrenia: results and methodological problems of evaluation].
Möller HJ
Nervenarzt; 2000 May; 71(5):345-53. PubMed ID: 10846709
[TBL] [Abstract][Full Text] [Related]
30. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies.
Correll CU; Leucht S; Kane JM
Am J Psychiatry; 2004 Mar; 161(3):414-25. PubMed ID: 14992963
[TBL] [Abstract][Full Text] [Related]
31. [Schizoaffective disorder: clinical symptoms and present-day approach to treatment].
Danileviciūte V
Medicina (Kaunas); 2002; 38(11):1057-65. PubMed ID: 12532717
[TBL] [Abstract][Full Text] [Related]
32. Safety in treating bipolar disorder.
Gupta S
J Fam Pract; 2003 Mar; Suppl():S26-9. PubMed ID: 12676082
[No Abstract] [Full Text] [Related]
33. Use of atypical antipsychotics in mood disorders.
Weizman R; Weizman A
Curr Opin Investig Drugs; 2001 Jul; 2(7):940-5. PubMed ID: 11757795
[TBL] [Abstract][Full Text] [Related]
34. Aripiprazole versus other atypical antipsychotics for schizophrenia.
Khanna P; Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; El-Sayeh HG; Leucht S
Cochrane Database Syst Rev; 2013 Feb; (2):CD006569. PubMed ID: 23450570
[TBL] [Abstract][Full Text] [Related]
35. Two new atypical antipsychotics: advantages and disadvantages.
Lemon MD
S D J Med; 1998 Aug; 51(8):285-6. PubMed ID: 9724957
[No Abstract] [Full Text] [Related]
36. The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
Citrome L; Volavka J
Postgrad Med; 2004 Oct; 116(4):49-51, 55-9, 63. PubMed ID: 15510593
[TBL] [Abstract][Full Text] [Related]
37. [Mechanisms of the body weight gain induced by novel antipsychotic drugs and concomitant lipid abnormalities].
Kostulski A; Wyszogrodzka-Kucharska A; Rabe-Jabłońska J
Przegl Lek; 2005; 62(9):938-43. PubMed ID: 16541734
[TBL] [Abstract][Full Text] [Related]
38. Relative weight gain among antipsychotics.
Masand PS
J Clin Psychiatry; 1999 Oct; 60(10):706-8. PubMed ID: 10549690
[No Abstract] [Full Text] [Related]
39. Care maps: atypical antipsychotics. Introduction.
Houltram B; Scanlan M
Nurs Stand; 2004 May 19-25; 18(36):42-4. PubMed ID: 15176111
[No Abstract] [Full Text] [Related]
40. Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders.
McDougle CJ; Stigler KA; Erickson CA; Posey DJ
J Clin Psychiatry; 2008; 69 Suppl 4():15-20. PubMed ID: 18533764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
